Profusa Inc. (PFSA): Market Cap to Revenue

Symbol and logo of brand Profusa Inc. (PFSA)

The P/S ratio chart for Profusa Inc (PFSA) demonstrates the impact of current demand for oxygen sensors, while 0.00 reflects the metric's baseline. The asset's value growth is based on a unique technology for integrating sensors into body tissues. However, high operating losses and challenges with FDA approval create overvaluation risks, which are critical to consider when analyzing market capitalization relative to revenue.

PFSA Profusa Inc. P/S Multiple (07/15/2025 - 07/15/2025)

Analytical breakdowns for Profusa, Inc. (PFSA)

- share price and consensus valuation forecast:
Price Performance Chart profusa.com|PFSA - Price Target Chart
- stock exchange capitalization data:
Market Valuation Profusa, Inc.|PFSA - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Profusa|PFSA - Book Capitalization|Capitalization to Book Value Ratio profusa.com|PFSA - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Profusa Inc|PFSA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Profusa, Inc|PFSA - Company Aggregate Debts|Debts to Book Capitalization Profusa, Inc.|PFSA - Company Long-Term Debt|Company Short-Term Debt Profusa|Intermediate Coverage Ratio profusa.com
- earnings and multiples data:
PFSA - Net Profit|Expected Net Profit Profusa Inc|PFSA - Price to Earnings Ratio|Forward Price to Earnings Multiple Profusa Inc.|PFSA - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Profusa, Inc.|PFSA - Operating profit EBITDA|Net earnings per share for the last four quarters Profusa|PFSA - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months profusa.com|PFSA - Earnings per share growth in current year|Expected earnings per share growth for next year Profusa Inc
- issuer revenue and sales details:
PFSA - Revenue and Sales Volume|Company Expected Sales Volume profusa.com|PFSA - Price-to-Revenue Ratio|Market Cap to Projected Revenue Profusa, Inc.
General company analysis:PFSA profusa.com
Core merchandise of Profusa Inc

Investing in Profusa Inc (PFSA) requires rigorous fundamental analysis to assess the fairness of its market value. The P/S ratio compares market capitalization to annual revenue, determining the price of one dollar of income and the risk of overpayment. By analyzing historical P/S levels, an investor can track the valuation trend of the business relative to its operational successes. The high value of human capital in biosensor development justifies a premium valuation of the issuer's equity.

Competitors of Profusa Inc

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|beyondair.net (XAIR) - Price-to-Revenue Ratio|Price-to-Sales Ratio SSKN (STRATA Skin Sciences, Inc.)|Price-to-Revenue Ratio GlucoTrack, Inc.|NAOV: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Venus Concept Corp (VERO)|NUWE - Price to Sales|P/S Multiple AEMD (Aethlon Medical)|ASXC (Asensus Surgical Inc) - Price-to-Sales Ratio|AVGR: Market Cap to Revenue|BSGM - P/S Multiple|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|KNW - Price-to-Revenue Coefficient|NARI (Inari Medical, Inc.) - P/S Multiple|P/S Multiple nevro.com|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio